Draft Biosimilar Red Tape Elimination Act: Pharmacist As Ally, Would Patients Benefit?
What's The Generics Experience?
If the bill on the Biosimilar Red Tape Elimination Act is passed, all biosimilars would be deemed interchangeable on US FDA approval. Scrip takes a look at what empowering pharmacists could mean, what the generics substitution experience shows and where possible pain points lie
